Latest filing published 28 May 2021 for FIBROGEN INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kalevi Kurkijarvi: trading record in brief
All filings by Kalevi Kurkijarvi on record concern Kyntra Bio, Inc., in the capacity of board member. In total, 90 filings cover trades dated from 19 January 2017 to 26 May 2021.
Every open-market trade on record is a sale: 56 sales worth €7.0M. Outside the open market, there are 4 share grants and 30 option exercises. 2021 to date brings no purchases and 4 sales.
The record was last updated on 28 May 2021 with a share grant in Kyntra Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kalevi Kurkijarvi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,700 shares0Common StockSEC:0001209191-21-036681:0
1 of 1 declaration
